Document Detail


The differential effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers with respect to foot ulcer and limb amputation in those with diabetes.
MedLine Citation:
PMID:  20840518     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Diabetic foot ulcers (DFU) or lower extremity amputation (LEA) are complications of diabetes. In those with diabetes, angiotensin-converting enzyme inhibitors (ACEi) and angiotensin receptor blockers (ARB) are commonly used to prevent the progression of kidney disease. Recent studies have indicated that angiotensin may affect angiogenesis and wound repair. Our goal was to evaluate in those with diabetes the likelihood of developing a DFU or LEA among users of ACEi or ARB using a retrospective cohort design of general practices in the United Kingdom. We studied 40,342 individuals at least 35 years of age with diabetes who were first prescribed ACEi or ARB between 1995 and 2006. A total of 35,153 individuals were treated with ACEi, 12,437 individuals with ARB, and 7,310 both. The hazard ratio for DFU was 0.50 (95% confidence intervals: 0.43, 0.59), showing an increased risk of DFU for those using ACEi vs. ARB. The hazard ratio for LEA was 0.72 (0.48, 1.01). However, among those with lower extremity peripheral arterial disease the hazard ratio was 0.45 (0.22, 0.91) for the new onset of a LEA. In conclusion, among those with diabetes, exposure to ACEi as compared with ARB increases the risk of developing a DFU or LEA.
Authors:
David J Margolis; Ole Hoffstad; Stephen Thom; Warren Bilker; Arturo R Maldonado; Robert M Cohen; Bruce J Aronow; Timothy Crombleholme
Related Documents :
9706128 - Foot problems in diabetes.
15973818 - The medical management of diabetes mellitus with particular reference to the lower extr...
10795028 - The diabetic foot.
8222428 - Exostectomy for symptomatic bony prominences in diabetic charcot feet.
10450378 - Plasma levels of endothelin-1 in diabetic retinopathy in pregnancy.
22618128 - Diagnosing and monitoring diabetic macular edema: structural and functional tests.
Publication Detail:
Type:  Comparative Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society     Volume:  18     ISSN:  1524-475X     ISO Abbreviation:  Wound Repair Regen     Publication Date:    2010 Sep-Oct
Date Detail:
Created Date:  2010-09-15     Completed Date:  2011-03-01     Revised Date:  2011-09-26    
Medline Journal Info:
Nlm Unique ID:  9310939     Medline TA:  Wound Repair Regen     Country:  United States    
Other Details:
Languages:  eng     Pagination:  445-51     Citation Subset:  IM    
Copyright Information:
© 2010 by the Wound Healing Society.
Affiliation:
Department of Dermatology and Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA. margo@mail.med.upenn.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Amputation / trends*
Angiotensin Receptor Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Disease Progression
England
Female
Follow-Up Studies
Foot Ulcer / drug therapy*,  surgery
Humans
Leg / surgery*
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Wales
Grant Support
ID/Acronym/Agency:
DK-080376/DK/NIDDK NIH HHS; DK074055/DK/NIDDK NIH HHS; DK74361/DK/NIDDK NIH HHS; K24 AR002212-10/AR/NIAMS NIH HHS; K24-AR002212/AR/NIAMS NIH HHS; U18HS016946/HS/AHRQ HHS
Chemical
Reg. No./Substance:
0/Angiotensin Receptor Antagonists; 0/Angiotensin-Converting Enzyme Inhibitors
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The role of surgical debridement in healing of diabetic foot ulcers.
Next Document:  Nanotechnology promotes the full-thickness diabetic wound healing effect of recombinant human epider...